AlphaYouDM
Insider selling
David Malcom Rodman sold $557K of Mineralys Therapeutics, Inc. (MLYS) stock
David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS), sold 20,407 shares of MLYS stock worth $557K, per an SEC Form 4 filed Jul 16, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 13, 2026, 3 days before it was made public.
MLYS has moved +2.6% since the trade date, from $27.59 to $28.31 (Sep 21, 2026 close).
- Traded
- Jul 13, 2026
- Disclosed
- Jul 16, 2026
- Filing delay
- 3 days
- Price since
- +2.6%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More MLYS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.